Tibet Duo Rui Pharmaceutical Co Ltd Class A 301075
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥17.54
- Day Range
- ¥17.58–18.65
- 52-Week Range
- ¥12.60–31.58
- Bid/Ask
- ¥18.47 / ¥18.48
- Market Cap
- ¥1.48 Bil
- Volume/Avg
- 2.8 Mil / 2.5 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 4.68
- Dividend Yield (Trailing)
- 0.68%
- Dividend Yield (Forward)
- 0.68%
- Total Yield
- 0.68%
Company Profile
Tibet Duo Rui Pharmaceutical Co Ltd is engaged in the research and development, production, and sales of chemical-pharmaceutical preparations and their raw materials.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 395
- Website
- http://www.duoruiyy.com
Comparables
Valuation
|
Metric
|
301075
|
000919
|
600211
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 58.45 | 12.42 |
Price/Book Value | 2.00 | 1.07 | 3.13 |
Price/Sales | 4.68 | 1.20 | 4.06 |
Price/Cash Flow | 131.97 | 15.61 | 9.42 |
Price/Earnings
301075
000919
600211
Financial Strength
|
Metric
|
301075
|
000919
|
600211
|
|---|---|---|---|
Quick Ratio | 7.18 | 3.28 | 2.65 |
Current Ratio | 8.32 | 3.61 | 2.80 |
Interest Coverage | −0.50 | 388.44 | 72.67 |
Quick Ratio
301075
000919
600211
Profitability
|
Metric
|
301075
|
000919
|
600211
|
|---|---|---|---|
Return on Assets (Normalized) | −0.52% | 1.25% | 14.77% |
Return on Equity (Normalized) | −0.71% | 1.83% | 20.58% |
Return on Invested Capital (Normalized) | −0.76% | 1.04% | 16.12% |
Return on Assets
301075
000919
600211
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Yvkqrkyvwt | Kyfp | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Dppdtdrkb | Bvlgpw | $78.0 Bil | |||
| Haleon PLC ADR
HLN
| Ygpphgdc | Qypr | $48.4 Bil | |||
| Viatris Inc
VTRS
| Hmwhdxc | Xqgz | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Qbyzmdkgc | Vtys | $13.5 Bil | |||
| Catalent Inc
CTLT
| Bkjsqmp | Qcjvgx | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Kzwyytrxm | Sqklq | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Zrmtchvd | Lgvw | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Mkxdyjvv | Ykgxk | $2.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Hbcqftt | Dbkj | $2.3 Bil |
United States